WHO Expands STI Guidance, Reviews Country Progress
WHO Updates STI Guidelines to Combat Rising Infections and Resistance
Table of Contents
New recommendations target key populations and service delivery for more effective prevention and care.
Teh World Health Institution (WHO) has released crucial new recommendations aimed at strengthening global efforts to prevent and manage sexually transmitted infections (STIs). These updates, set to be incorporated into forthcoming consolidated guidelines, address persistent policy and service gaps, especially for asymptomatic STIs, and aim to accelerate progress towards the 2030 Enduring Progress Goals for STIs.
Key Recommendations for Enhanced STI Prevention and Care
The revised guidance emphasizes a more targeted approach to STI screening and service delivery, recognizing the diverse needs and risk profiles of different populations.
Expanding Screening and Surveillance
New recommendations include targeted screening for gonorrhea and chlamydia in settings with high prevalence and available resources. The focus is specifically on pregnant women, adolescents and young peopel aged 10-24, sex workers, and men who have sex with men (MSM).Screening strategies should be tailored to individual risk and resource availability, with annual or 6-monthly screening recommended for sex workers and MSM.
The updated guidance also covers a broader spectrum of STIs, including chlamydia, syphilis, trichomoniasis, genital candidiasis, Mycoplasma genitals, human papillomavirus (anogenital warts), and bacterial vaginosis. It also highlights the importance of syphilis testing and partner services.
Improving Service Delivery Models
To enhance accessibility and effectiveness, the WHO recommends several service delivery improvements. These include decentralizing and integrating STI services into primary healthcare settings, task sharing with trained healthcare providers and community health workers, and leveraging digital tools to complement in-person care.
“These new recommendations aim to close persistent policy and service gaps, especially for asymptomatic STIs, and help countries move faster toward the 2030 goals,” stated Dr. Meg Doherty, Director of WHO’s Global HIV, Hepatitis and STIs Programmes.
Mixed Progress in National STI Policy Implementation
Alongside the new recommendations, the WHO has released data highlighting both progress and ongoing challenges in the adoption and implementation of WHO policies by countries.
National strategies and Guidelines
While a meaningful majority of countries reporting to Global AIDS Monitoring (89%) have a national STI strategy or action plan, only 43% have updated it since 2023. Similarly,although 97% of countries report having national case management guidelines,only half have revised them since 2020. This indicates a critical need for more frequent policy updates to reflect current epidemiological trends and best practices.
Surveillance and Resistance Monitoring
Gonococcal resistance monitoring remains a concern, with only 37% of countries conducting routine surveillance. This limited data hinders effective treatment strategies for gonorrhea, a growing public health challenge.
advances in Testing and Prevention
Encouragingly, 95 countries have integrated dual HIV/syphilis rapid tests into their national policy, with nearly half of these countries adopting them for both pregnant women and key populations. This integration is vital for early detection and prevention of mother-to-child transmission.
National plans to eliminate mother-to-child transmission of HIV and syphilis are in place in 72% of reporting countries. Furthermore, a substantial 76% of WHO Member States (147 countries) have included the human papillomavirus (HPV) vaccine in their national immunization schedules, a critical step in preventing cervical cancer.
Urgent Need for Accelerated Action
The WHO’s findings underscore the urgent necessity for countries to accelerate the updating of national policies, expand surveillance capabilities, and bridge implementation gaps. STIs continue to pose a significant burden of morbidity and mortality globally. Ensuring the provision of quality STI prevention and care services remains paramount to reducing STI prevalence and preventing long-term complications. The new recommendations and ongoing data analysis by WHO are critical tools in this global fight.